NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Total assets, 2025
- $4.6B
- YoY, 2025
- +24.5%
- 5-year CAGR
- +21.7%
- 10-year CAGR
- +25.6%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $4.6B | +24.5% |
| 2024 | $3.7B | +14.4% |
| 2023 | $3.3B | +37.3% |
| 2022 | $2.4B | +14.3% |
| 2021 | $2.1B | +19.5% |
| 2020 | $1.7B | +32.8% |
| 2019 | $1.3B | +31.5% |
| 2018 | $993M | +21.5% |
| 2017 | $818M | +123.9% |
| 2016 | $365M | −23.1% |
| 2015 | $475M | +95.4% |
| 2014 | $243M | +57.1% |
| 2013 | $155M | −21.1% |
| 2012 | $196M | +41.6% |
| 2011 | $138M | −4.2% |
| 2010 | $144M | — |